Enterprise Products Partners is a winner

Illumina: “Illumina is great, not just because [CNBC contributor Dr. Scott Gottlieb] is on the board. They have incredible technology and I love the diagnostics industry. Buy Illumina. ”

Atai Life Sciences NV: “This is one that is down so low that it’s just a fantastic specification, to be honest. You do not know, it’s a roll of the dice, but there are specifications and I would not sell it down here. $ 6, I would be a buyer. ”[ads1];

Riskified: “No, no. It was listed in July. It’s just an invitation to be [crushed like shares of Peloton have recently been]. For that security, buy NortonLifeLock. We own it too [CNBC Investing Club] and a very big deal is approaching. I think it’s the one you should be in. ”

Doximity: “Well, I was right for a while. Now I’m wrong. I think doctors love it. Ask your doctor. They will swear to it. This is not Teladoc by the way, which has been completely [crushed like shares of Peloton have recently been], if not toasted. I think DOCS is good, but like I said, I’m wrong. I think it is an indispensable product, and they make money, which for me means good growth. ”

Enterprise Products Partners: “I like EPD. You have a good return. You have growing volumes now. You have solid management, giving 7.8% [at roughly $22 per share]. It’s a winner. I wish [co-CEO] Jim Teague would come on. That would be great.”

CNH Industrial: “I like it very, very much. Anything [agriculture,] you know I like Deere. I’m yours too. I also like AGCO. I think it’s a winner. ”

SoFi Technologies: “Well, maybe what happened … is that it should never have been up there. And by the way, someone did an incredible secondary and got out of that thing at a very good price. I actually want to know more about the secondary than I wanted about the stock. ”

Register now for the CNBC Investing Club to follow Jim Cramers every move in the market.